Clinical trial
Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines: an Open-label, Non-inferiority, Multicentre, Randomised Phase 3 Trial
NCT05519956 is registered in ClinicalTrials.gov with Fujian Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines: an Open-label, Non-inferiority, Multicentre, Randomised Phase 3 Trial
- Lead sponsor
- Fujian Cancer Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- September 16, 2022
- Completion date
- September 30, 2025
- Enrollment
- 398 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.